Leerink raised the firm’s price target on BrightSpring Health (BTSG) to $49 from $39 and keeps an Outperform rating on the shares.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BTSG:
- BrightSpring Health Services Projects Strong 2026 Growth
- BrightSpring Health sees FY26 revenue $14.45B-$15B, consensus $14.62B
- BrightSpring Health reports Q4 adjusted EPS 33c, consensus 35c
- BrightSpring Health Services, Inc. (BTSG) Q4 Earnings Cheat Sheet
- BrightSpring Health price target raised to $55 from $50 at BTIG